Helps to improve immune system, inflammatory diseases, quality of life psoriasis and cancer sufferers
Scientifically formulated palatable premixed organic based soybean powder powered by 750mg wild crafted AFA (Aphanizomenon flos-aquae) Blue Green Algae from Klamath Lake, Oregon of United States of America. EnerFlex® AFA750 is proprietary name of MYHEALTHDRIVER is an innovative dietary formula developed back in 2003 and designed to be consumed as a beverage to help cells detox, tissue rejuvenation, organs repair and making our immune system more effective against viral infections.
AFA Blue Green Algae are well known for its antioxidant, anti-viral, and intrinsic anti-inflammatory properties and has significant hepatoprotective effect. EnerFlex® AFA750 had been evaluated in two clinical aspects: 1) to help improve the quality of life in various types of cancer patients undergoing chemo and radiotherapy 2) to help relieve severe psoriasis (especially in plaque, erythrodermic and scalp psoriasis) but eventually we found a 100% cure for the very severe type psoriasis when EnerFlex® AFA750 is used together with EnerFlex® PROBIOTIC and EnerFlex® COMPLEXION.
Dubbed “Earth’s first food,” AFA is a species of cyanobacteria (blue-green microalgae), which are among the most ancient of all living organisms. For at least 3.5 billion years cyanobacteria have provided oxygen to the atmosphere and nutrients to the myriad varieties of life forms that inhabit Earth’s freshwater sources. AFA is one of the most nutrient-dense organism in the world containing more than 100 nutrients, rich in colloidal mineral, selenium, phycocyanin (blue) and chlorophyll (green) pigments, carotenoids (namely beta carotene, lycopene and lutein), various types of mono and polyunsaturated fatty acids including DHA and EPA (from AFA).
Today, extensive researches showed that AFA is unique food due to its following features:
- Natural Cox-2 Inhibitor and Leukotriene B4 Inhibitor – thus to be beneficial as natural pain killer, anti-asthmatic and anti-cancer by phycocyanin pigment
- Immune System Enhancer via:
- Macrophages Activation against bacteria invasions
- Anti-viral via Natural Killer Cell Migration Enhancement - increase in immune surveillance by NK cells after AFA consumption, which could lead to fewer colds and less viral infections.
- Lymphocytes B and T cells mobilization
- Rich in PEA (Phenylethylamine), a derivative of the amino acid phenylalanine. Studies suggest that PEA regulates neurons and transmits signals between neurons in the central nervous system. In another word, AFA modulates brain cell function by releasing neurotransmitters (norepinehprine and dopamine) to help enhance mood, focus, alleviate depression, healthy blood pressure, vision acuity and cognitive function.
- Bone Marrow Stem Cell Enhancer – thus helps constant organ repair and anti-aging when it is consumed regularly
EnerFlex® AFA750 is suitable for the following users:
General wellness, cancer patients undergoing chemotherapy or radiotherapy, severe eczema and psoriasis, depression, moody, stressful, viral infections and organs fail to function properly due to unknown causes or chronic conditions.
Direction of use: 1 - 4 sachets a day
黑暗中的曙光 …
有助改善免疫系統, 炎症性疾病, 牛皮癣/銀屑病及癌症患者生活素質
可口預混有機大豆區域食療配方具有蛋白質對碳水化合物的比例0.6- 1.0, 添加750毫克野生AFA藍綠藻 (Aphanizomenon flos-aquae源於美國俄勒岡州末克拉馬斯湖)，非轉基因大豆分離蛋白，菊粉和耐消化糊精。EnerFlex®AFA750是MYHEALTHDRIVER專有名稱,是早在2003年自創食療配方，以幫助細胞排毒，復原組織，器官修復，使我們免疫系統更有效對抗病毒感染。
AFA藍綠藻是眾所周知的抗氧化，抗病毒，和固有抗炎性質，並具有顯著保肝作用。EnerFlex®AFA750曾在兩項臨床方面進行評估：1）幫助接受化療和放療各類癌症患者改善生活質量 2）有助於緩解重度牛皮癣/銀屑病（特別是在斑塊，紅皮及頭皮銀屑病），但最終我們當發現EnerFlex®AFA750與EnerFlex®PROBIOTIC及EnerFlex®COMPLEXION一起使用100％的治愈非常嚴重的類型牛皮癣/銀屑病。
AFA藍綠藻被稱為“地球上的首屆食品” 也是最古老的生物為至少35億多年。AFA含有超過100 種的營養物質，是世界上最營養豐富的生物之一, 含有豐富的膠體礦物，硒，藻藍蛋白（藍色）和葉綠素（綠色）色素，類胡蘿蔔素（即β-胡蘿蔔素，番茄紅素和葉黃素），單元和多元不飽和脂肪酸，包括DHA和EPA（來自AFA）。
如今，大量的研究表明AFA是獨特食品由於其特點如下：
- 天然COX-2抑製劑和白三烯B4抑製劑 - 從而作為天然止痛，抗哮喘和抗癌由於含有豐富的藻藍蛋白顏料
- 增強免疫系統通過：
- 激活巨噬細胞對細菌的入侵
- 自然殺傷細胞遷移增強抗病毒 - 由NK細胞遷移AFA增加免疫監視，這可能導致更少的感冒和更少的病毒感染。
- 淋巴細胞B和T細胞的遷移使我們免疫系統更有效對抗病毒感染
- 富含PEA（苯乙胺），苯丙氨酸的衍生物。研究表明，PEA調節神經元和中樞神經系統發送的神經元之間的信號。換句話說，AFA調製通過釋放神經遞質（norepinehprine和多巴胺），以幫助提高情緒，焦點，減輕抑鬱，健康血壓，視力和認知功能的腦細胞的功能。
- 骨髓幹細胞增強 - 從而經常食用有助於不斷修復器官和抗老化
EnerFlex®AFA750適用於以下用戶:
一般保健，接受化療和放療各類癌症患者, 嚴重的濕疹和牛皮癬，抑鬱，喜怒無常，壓力，病毒感染和器官原因不明無法正常的運作或者慢性疾病狀況不受控制
使用方法：每日1 - 4包
About EnerFlex AFA750
Active Ingredients
Wholesome organic Aphanizomenon flos-aquae Blue Green Algae (AFA) and soybean concentrate, Non-GMO soy protein isolate and indigestible maltodextrin (patented dietary fibre derived from cornstarch)
Benefits
Helps strengthen immune system , modulate central nervous system and tissue repair
Mode of Action
Triple essential actions for cancer care:
- Immune System Enhancer by AFA (Natural Killer Cell Enhancer)
- Dopamine Modulation
- Stem Cell Enhancer by AFA
Direction of Use
Dissolve 1-2 sachets of 20g powder in approximately 120-240ml of warm water and drinks immediately. Consume 1-3 times daily. For best result, add 1 sachet of EnerFlex PROBIOTIC with each sachet of EnerFlex AFA750 daily.
產品簡介
主要成分
有机AFA蓝绿藻及大豆精华，非基因改造大豆蛋白质及非消化形玉米麦芽糖糊精（膳食纤维）
保健效益
有助增强免疫系统，调和神经系统及细胞修复
运作功能
三项有助癌症患者运作功能:
- AFA蓝绿藻有助增强免疫系统
- 改善神经系统（通过 DOPAMINE MODULATION）运作
- 促进干细胞运作以促进细胞维修或重生
使用方法
将1-2包20克粉溶解于120-240ml 的温水。用摇杯将它完全溶解及马上饮用。每天饮用一至三次。与一包EnerFlex PROBIOTIC一起饮用，将使免疫系统如虎添翼。
Competitive Edge
FOOD that works with MEDICINAL PROPERTIES
- FAST ACTING FUNCTIONAL FOOD… POSITIVE EFFECT WITHIN 7–28 DAYS
- CAN BE USED AS MEAL REPLACEMENT IN PATIENTS REQUIRED LIQUID FOOD
- CONTAINS 20 TYPES OF AMINO ACIDS, ANTIOXIDANTS, CHLOROPHYLL, PUFA, VITAMINS, LIFE ENZYMES AND COLLOIDAL MINIERALS
- SAFE FOR LONG-TERM USE AND EASILY ABSORBED BY HUMAN BODY
产品特点
拥有食疗功效食物!
- 效果快!可在7-28天见效
- 病人亦可当代餐使用
- 富含二十种氨基酸，抗氧化素，叶绿素，不包和脂肪酸，维他命，活性酵素及矿物质
- 可安全长期使用并容易被人体吸收
2 CASE STUDIES by a Consultant Physician in General Hospital Kuala Lumpur, Malaysia
CASE STUDY 1
Patient: Male. Age: 71; Race: Malay
Type of Cancer: Ca Lung Stage 3b
Chemotherapy: Carboplcatin, Gemsar – 2nd Cycle
Centre: General Hospital Kuala Lumpur, Malaysia
| Study Symptom | Co-existing Symptom(s) before EnerFlex AFA750 | Improved | No Change |
|---|---|---|---|
| Nausea | + | + | |
| Constipation | + | + | |
| Dizziness | |||
| Diarrhoea | |||
| Flatulence | |||
| Insomnia | + | + | |
| Appetite | Poor | + | |
| Taste Buds | Poor | + |
Comment from Physician in-charge:
Patient was feeling better since no more nausea or vomiting. Chemotherapy was taken before EnerFlex AFA750 . Thus, improvement in reduction of nausea was obviously due to EnerFlex AFA750. Other conditions remained.
| Study Symptom | Co-existing Symptom(s) before EnerFlex AFA750 | Improved | No Change |
|---|---|---|---|
| Nausea | + | + | |
| Constipation | + | + | |
| Dizziness | |||
| Diarrhoea | |||
| Flatulence | |||
| Insomnia | + | + | |
| Appetite | Poor | + | |
| Taste Buds | Poor | + |
Comment from Physician in-charge:
Patient was feeling better and better tolerant to sign and symptoms of chemotherapy. Looking better, ambulating and back to work!
CASE STUDY 2
Patient: Male. Age: 59; Race: Malay
Type of Cancer: Well-differentiated Ca Lung Stage 3b
Operated on 10/10/03
Centre: General Hospital Kuala Lumpur, Malaysia
| Study Symptom | Co-existing Symptom(s) before EnerFlex AFA750 | Improved | No Change |
|---|---|---|---|
| Nausea | + | ||
| Constipation | + | + | |
| Dizziness | + | ||
| Diarrhoea | - | ||
| Flatulence | - | ||
| Insomnia | + | ||
| Appetite | Poor | + | |
| Taste Buds | Poor |
Comment from Physician in-charge:
Patient showed improvement in symptoms.
A 4-week follow-up observational study by Nilai Cancer Hospital, Malaysia
Stomach Cancer, NPC, Breast Cancer, Lung Cancer, Osteoblast Cancer, Sigmoid Colon Cancer, Malignant Mixed Mullerian Tumour, Giant Cell Tumour
LUNG CANCER
Patient: Female. Age: 38; Race: Chinese
Type of Cancer: Ca Lung
Chemotherapy: i.v. Taxotere 20mgm/weekly x 6 weeks
Centre: Nilai Cancer Hospital, Malaysia
| Study Symptom | Co-existing Symptom(s) before EnerFlex AFA750 | Improved | No Change |
|---|---|---|---|
| Nausea | + | ||
| Constipation | |||
| Dizziness | + | + | |
| Diarrhoea | |||
| Flatulence | + | + | |
| Insomnia | |||
| Appetite | Poor | + | |
| Taste Buds |
Comment from Physician in-charge:
Felt better but no improvement in disease progression yet.
OSTEOSARCOMA
Patient: Female. Age: 16; Race: Chinese
Type of Cancer: Osteosarcoma, Left Knee Joint
Chemotherapy: Not indicated
Centre: Nilai Cancer Hospital, Malaysia
| Study Symptom | Co-existing Symptom(s) before EnerFlex AFA750 | Improved | No Change |
|---|---|---|---|
| Nausea | |||
| Constipation | + | + | |
| Dizziness | |||
| Diarrhoea | +/- | + | |
| Flatulence | + | + | |
| Insomnia | +/- | + | |
| Appetite | Good | + | |
| Taste Buds | Good | + |
Comment from Physician in-charge:
Felt better on regular usage. Very much improved in appetite, taste buds, insomnia and diarrhoea.
CA SIGMOID COLON
Patient: Male. Age: 67; Race: Indian
Type of Cancer: Sigmoid Colon
Chemotherapy: i.v. Folinic acid 35mgm, i.v. 5FU 700mgm; Radiotherapy
Centre: Nilai Cancer Hospital, Malaysia
| Study Symptom | Co-existing Symptom(s) before EnerFlex AFA750 | Improved | No Change |
|---|---|---|---|
| Nausea | |||
| Constipation | |||
| Dizziness | |||
| Diarrhoea | |||
| Flatulence | |||
| Insomnia | +/- | + | |
| Appetite | Good | + | |
| Taste Buds | Good | + |
Comment from Physician in-charge:
Patient complained about abdominal pain after 7 days and stopped consuming. Abdominal pain and fever was due to infection and not the product.
STOMACH CANCER
Patient: Female. Age: 75; Race: Chinese
Type of Cancer: Stomach Cancer
Chemotherapy: UFT 300mg TID, FA 15mg TID
Centre: Nilai Cancer Hospital, Malaysia
| Study Symptom | Co-existing Symptom(s) before EnerFlex AFA750 | Improved | No Change |
|---|---|---|---|
| Nausea | + | ||
| Constipation | |||
| Dizziness | + | ||
| Diarrhoea | |||
| Flatulence | + | ||
| Insomnia | +/- | + | |
| Appetite | Average | + | |
| Taste Buds | Good | + |
Comment from Physician in-charge:
Tolerating well and finds it is useful as all symptoms have subsided considerably.
BREAST CANCER
Patient: Female. Age: 51; Race: Indian
Type of Cancer: Breast Cancer
Chemotherapy: i.v.Taxol 160mgm, i.v.Carboplatin 150mgm
Centre: Nilai Cancer Hospital, Malaysia
| Study Symptom | Co-existing Symptom(s) before EnerFlex AFA750 | Improved | No Change |
|---|---|---|---|
| Nausea | |||
| Constipation | |||
| Dizziness | |||
| Diarrhoea | |||
| Flatulence | + | ||
| Insomnia | + | ||
| Appetite | Average | + | |
| Taste Buds | Good | + |
Comment from Physician in-charge:
Tolerating well and felt better in overall well being.
NPC
Patient: Male. Age: 63; Race: Chinese
Type of Cancer: Nasopharynx Cancer
Chemotherapy: not indicated
Centre: Nilai Cancer Hospital, Malaysia
| Study Symptom | Co-existing Symptom(s) before EnerFlex AFA750 | Improved | No Change |
|---|---|---|---|
| Nausea | |||
| Constipation | + | + | |
| Dizziness | |||
| Diarrhoea | |||
| Flatulence | + | + | |
| Insomnia | + | + | |
| Appetite | Good | + | |
| Taste Buds | Good | + |
Comment from Physician in-charge:
Comfortable with the product. Much better in bowel movement and appetite, flatulence and insomnia.
GIANT CELL TUMOUR
Patient: Male. Age: 63; Race: Chinese
Type of Cancer: Nasopharynx Cancer
Chemotherapy: not indicated
Centre: Nilai Cancer Hospital, Malaysia
| Study Symptom | Co-existing Symptom(s) before EnerFlex AFA750 | Improved | No Change |
|---|---|---|---|
| Nausea | |||
| Constipation | + | + | |
| Dizziness | + | +++ | |
| Diarrhoea | + | + | |
| Flatulence | + | + | |
| Insomnia | |||
| Appetite | Average | + | |
| Taste Buds | Poor | + |
Comment from Physician in-charge:
Happy with the product.
NPC
Patient: Female. Age: 56; Race: Chinese
Type of Cancer: Nasopharynx Cancer
Chemotherapy: not indicated; Radiotherapy
Centre: Nilai Cancer Hospital, Malaysia
| Study Symptom | Co-existing Symptom(s) before EnerFlex AFA750 | Improved | No Change |
|---|---|---|---|
| Nausea | + | + | |
| Constipation | |||
| Dizziness | |||
| Diarrhoea | |||
| Flatulence | |||
| Insomnia | + | + | |
| Appetite | Average | + | |
| Taste Buds | Poor | + |
Comment from Physician in-charge:
Well tolerated and found useful as all her symptoms noted improved considerably.
NPC
Patient: Male. Age: 46; Race: Chinese
Type of Cancer: Nasopharynx Cancer
Chemotherapy: not indicated; Radiotherapy
Centre: Nilai Cancer Hospital, Malaysia
| Study Symptom | Co-existing Symptom(s) before EnerFlex AFA750 | Improved | No Change |
|---|---|---|---|
| Nausea | + | + | |
| Constipation | |||
| Dizziness | + | + | |
| Diarrhoea | + | + | |
| Flatulence | + | + | |
| Insomnia | + | + | |
| Appetite | Poor | + | |
| Taste Buds | Poor | + |
Comment from Physician in-charge:
Patient felt dryness on the mouth, advised to drink plenty of water.
NPC
Patient: Male. Age: 58; Race: Chinese
Type of Cancer: Nasopharynx Cancer
Chemotherapy: Cisplatin 30mgm/week; Radiotherapy
Centre: Nilai Cancer Hospital, Malaysia
| Study Symptom | Co-existing Symptom(s) before EnerFlex AFA750 | Improved | No Change |
|---|---|---|---|
| Nausea | + | + | |
| Constipation | |||
| Dizziness | + | + | |
| Diarrhoea | |||
| Flatulence | + | + | |
| Insomnia | + | + | |
| Appetite | Poor | + | |
| Taste Buds | No taste bud | + |
Comment from Physician in-charge:
Patient felt better and decided to stay with the product.
STOMACH CANCER
Patient: Male. Age: 49; Race: Indian
Type of Cancer: Stomach Cancer
Chemotherapy: not indicated; Radiotherapy
Centre: Nilai Cancer Hospital, Malaysia
| Study Symptom | Co-existing Symptom(s) before EnerFlex AFA750 | Improved | No Change |
|---|---|---|---|
| Nausea | |||
| Constipation | |||
| Dizziness | |||
| Diarrhoea | |||
| Flatulence | + | + | |
| Insomnia | + | + | |
| Appetite | Good | + | |
| Taste Buds | Good | + |
Comment from Physician in-charge:
Patient felt better and decided to stay with the product.
The Expectation
What can cancer patients expect after 7 days of product consumptions?
Improvement in quality of life due to chemo/radiotherapy
產品效果
癌症患者服用了7天后又和效益?
有助改善化疗及电疗引发的不适状况